Darling Ingredients (DAR) Q1 2025: Core EBITDA Rises 15% as Margin Tailwinds Offset DGD Drag

April 24, 2025 | By EarningsIQ Research

Core operating momentum accelerated for Darling Ingredients in Q1 2025, as fat price tailwinds and disciplined cost management offset a sharp downturn in DGD (Diamond Green Diesel) joint venture results. Management’s reaffirmed full-year outlook hinges on a normalized renewables policy environment and continued feed segment strength, with investors closely watching regulatory clarity and RIN (Renewable Identification Number) price signals for the rest of the year.

Summary

• Feed Segment Resilience: Core feed and food businesses outperformed as fat prices rose, mitigating DGD volatility.
• Renewables Policy Overhang: Biofuels margin recovery and 45Z tax credit optimization drive cautious optimism.
• Capital Allocation Discipline: Deleveraging and opportunistic buybacks remain priorities amid uncertain external drivers.

Performance Analysis

Darling’s Q1 2025 results demonstrated a clear divergence between its core ingredient operations and its renewable fuels exposure. While DGD’s EBITDA contribution plummeted due to tax credit transitions, supply chain adjustments, and downtime, the underlying feed and food ingredients businesses delivered improved year-over-year EBITDA on stable volumes and higher fat prices. Core adjusted EBITDA (excluding DGD) rose to approximately $190 million, up from $165 million a year ago, with feed segment sales and margins benefiting from a late-quarter surge in domestic fat prices and resilient rendering volumes.

The food segment, led by collagen and gelatin, saw a rebound in margins and volumes as industry destocking abated and new product innovation gained traction. Fuel segment results remained clouded by DGD’s underperformance, but management emphasized that the worst of the policy-driven volatility is likely behind them. Debt reduction of $146 million and $35 million in share repurchases reflected ongoing capital discipline, with leverage down to 3.33x and liquidity robust.

• Feed Margin Expansion: Rising fat prices and stable rendering volumes drove feed EBITDA above prior-year levels despite one-off inventory impacts.
• Food Segment Recovery: Collagen and specialty peptides posted higher margins as destocking ended and new products like TIDA gained momentum.
• DGD Volatility: Transition from blenders to producers tax credit, supply chain rework, and downtime led to a $109 million YoY EBITDA decline for DGD.

Management’s confidence rests on the core business's ability to generate cash flow and withstand external shocks, while the renewables segment’s recovery remains contingent on policy clarity and market discipline.

Executive Commentary

Strategic Positioning

1. Diversified Ingredient Model Shields Against Renewables Volatility

Darling’s global rendering and ingredient platform, which repurposes over 15% of global meat and food waste, provides a resilient cash flow base. Feed and food segments now account for the bulk of underlying EBITDA, offering a buffer as DGD navigates regulatory and margin turbulence.

2. Policy-Driven Biofuels Exposure Creates Both Risk and Optionality

DGD’s Q1 underperformance was driven by the shift from the blender’s tax credit (BTC) to the producer’s tax credit (PTC), supply chain reconfiguration, and downtime. Management expects full PTC benefit recognition on eligible feedstocks in Q2, with the RIN market and RVO (Renewable Volume Obligation) setting dictating forward profitability. Renewable diesel and SAF (sustainable aviation fuel) demand remain robust, but execution is dependent on policy stability and credit monetization.

3. Fat Price Tailwinds and Market Discipline Support Core Earnings Visibility

Domestic fat prices surged in March, providing a material lift to feed segment results. Management’s forward sales book, typically 60-90 days, enables visibility and risk management in volatile markets. Industry discipline, with idled capacity and rising RINs, supports margin recovery in the renewables segment.

4. Innovation in Collagen and Peptides Expands Food Segment Profitability

Next Data, collagen-based health products, and TIDA, a glucose moderation peptide, are gaining commercial traction. Higher-margin specialty products are increasing food segment EBITDA, with management expecting further upside as clinical trials and CPG partnerships develop.

5. Deleveraging and Opportunistic Buybacks Prioritized Over Growth Capex

Capital allocation remains focused on debt reduction, with leverage targeted below 2.5x by early 2026. Share repurchases are opportunistic and secondary to balance sheet strength, reflecting caution amid external uncertainty. Growth investments, such as a second SAF line, are on hold pending greater policy and market clarity.

Key Considerations

Q1 highlighted the value of Darling’s diversified model and management’s focus on execution amid policy-driven volatility. Investors should weigh the following:

Key Considerations:

• Biofuels Policy Sensitivity: Renewables segment results remain highly exposed to PTC, RIN, and RVO outcomes, with management guidance excluding potential RVO upside.
• Feedstock Pricing Leverage: Each cent per pound increase in fat prices translates to $12-$15 million in EBITDA, amplifying the impact of commodity moves.
• Food Segment Optionality: Collagen and peptide innovation is expanding addressable markets and margin profile, with CODEAGE channel and clinical trials as near-term catalysts.
• Balance Sheet Focus: Deleveraging remains the top capital priority, with buybacks opportunistic and growth capex gated by regulatory clarity.
• Tariff Impact Nuance: Tariffs support domestic fat prices and core margins, but limit protein exports to China and require supply chain adaptation for renewables.

Risks

Darling faces elevated external risk from biofuels policy uncertainty, including RIN price volatility, delayed RVO setting, and potential shifts in LCFS (Low Carbon Fuel Standard) implementation. Feedstock cost inflation, regulatory unpredictability, and global trade flows could pressure margins or disrupt supply. Management’s guidance assumes a stable to improving policy environment, which remains outside their direct control.

Forward Outlook

For Q2 2025, Darling expects:

• Core ingredient EBITDA to maintain the March run rate, with continued fat price tailwinds.
• Full PTC benefit recognition on eligible DGD feedstocks, supporting renewables margin recovery.

For full-year 2025, management reaffirmed combined adjusted EBITDA guidance of $1.25 billion to $1.3 billion.

• Core business momentum and feed price visibility underpin confidence.
• Renewables segment recovery depends on RIN pricing, policy clarity, and supply chain normalization.

Management highlighted that potential RVO upside is not embedded in guidance, positioning the outlook as conservative if policy aligns favorably.

Takeaways

Darling’s Q1 2025 results reinforce the strategic value of its diversified model and underscore the importance of policy and commodity tailwinds for forward results.

• Core Strength: Feed and food segments provided resilient cash flow and margin expansion, offsetting DGD volatility and supporting deleveraging.
• Policy Leverage: Renewables segment recovery is contingent on regulatory clarity and market discipline, with material upside if RVO and RINs move favorably.
• Innovation Watch: Collagen and peptide product pipeline offers incremental growth and margin expansion; watch for trial results and CPG adoption in H2 2025.

Conclusion

Darling Ingredients delivered a quarter of operational resilience and strategic focus, with core businesses gaining strength even as renewables exposure remains volatile. Execution on deleveraging, innovation, and disciplined capital allocation positions the company well, but the outlook is highly sensitive to external policy and market developments.

Industry Read-Through

Darling’s Q1 results signal that diversified ingredient models with exposure to both food and renewables are better positioned to weather policy and commodity shocks. The experience with DGD highlights the ongoing risk of regulatory whiplash for biofuels producers, especially as the market transitions from blender to producer tax credits and awaits RVO clarity. Rising domestic fat prices and supply chain discipline are supporting margin recovery across the rendering and feedstock ecosystem, while innovation in health-oriented ingredients is creating new growth vectors for ingredient suppliers. Investors in the broader renewables and ag-processing space should closely monitor RIN price trends, tariff regimes, and the pace of regulatory decision-making, as these factors will drive capital allocation and margin visibility across the sector.

DAR Materials Specialty Ingredients Renewable Fuels Deleveraging Collagen Tariffs Biofuels Policy